Nexpoint Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Nexpoint Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-72,587	Closed	-$1.74M	–	237
2021 Q1	$1.74M	Buy	+72,587	New	+$1.35M	0.45%	42

Nexpoint Asset Management's GNMK Position: Q2 2021 in Review

Nexpoint Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 72,587 shares — an estimated $1.74M sold.

Nexpoint Asset Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1.74M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Nexpoint Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Nexpoint Asset Management sold 72,587 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.74M.
Nexpoint Asset Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Nexpoint Asset Management's GenMark Diagnostics, Inc position peaked at $1.74M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Nexpoint Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.